Guixiong Zhang - The First Affiliated Hospital, Sun Yat-Sen University

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Development and Validation of Nomogram Including Mutations in Angiogenesis-Related Genes As Risk Factors for HCC Patients Treated with TACE

Wanqing Shen, Zhi Li, Jinyi Huang,Guixiong Zhang, Yiyang Tang,Wenzhe Fan,Jiaping Li

Translational oncology (2025): 102437-102437

引用0浏览0WOS引用

Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Intermediate-Stage HCC Exceeding the Up-7 Criteria: a Retrospective Cohort Study

Miao Xue,Yanqin Wu, Yiyang Tang, Kun Huang, Haikuan Liu, Bowen Zhu,Jie Wen,Yue Zhao,Guixiong Zhang, Hang Liu,Wenzhe Fan,Jiaping Li

Frontiers in Immunology (2025)

引用0浏览0引用

Simultaneous Versus Sequential Transcatheter Arterial Chemoembolization Combined with Microwave Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score-Matched Analysis

Hong-Yu Wang,Gui-Xiong Zhang,Wen-Zhe Fan, Jin-Wei Li, Shu-Fang Hao, Yu-Shu Ouyang,Jia-Ping Li,Wen-Dao Liu

Hepatobiliary & pancreatic diseases international HBPD INTno. 3 (2025): 286-293

引用0浏览0WOS引用

Integrated Machine Learning Screened Glutamine Metabolism-Associated Biomarker SLC1A5 to Predict Immunotherapy Response in Hepatocellular Carcinoma

Guixiong Zhang,Yitai Xiao, Hang Liu,Yanqin Wu,Miao Xue,Jiaping Li

Immunobiologyno. 5 (2024): 152841-152841

引用1浏览0WOS引用

Elevated SLC1A5 Associated with Poor Prognosis and Therapeutic Resistance to Transarterial Chemoembolization in Hepatocellular Carcinoma

Guixiong Zhang,Yitai Xiao,Jizhou Tan, Hang Liu,Wenzhe Fan,Jiaping Li

JOURNAL OF TRANSLATIONAL MEDICINEno. 1 (2024)

引用0浏览0WOS引用

Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma

Xiaokai Zhang,Jie Wen,Guixiong Zhang,Wenzhe Fan,Jizhou Tan,Haikuan Liu,Jiaping Li

TRANSLATIONAL ONCOLOGY（2023）

引用2浏览0WOS引用

Dissecting a Hypoxia-Related Angiogenic Gene Signature for Predicting Prognosis and Immune Status in Hepatocellular Carcinoma

Guixiong Zhang,Yitai Xiao,Xiaokai Zhang,Wenzhe Fan,Yue Zhao,Yanqin Wu, Hongyu Wang,Jiaping Li

Frontiers in Oncology（2022）

引用2浏览0WOS引用

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE

Hongyu Wang,Guixiong Zhang,Wenzhe Fan,Yanqin Wu,Jiang Zhang,Miao Xue,Yue Zhao, Wang Yao,Jiaping Li

Cancer Management and Research（2022）

引用7浏览0WOS引用

OIT3 Serves As a Novel Biomarker of Hepatocellular Carcinoma by Mediating Ferroptosis Via Regulating the Arachidonic Acid Metabolism

Jie Wen,Abudureyimujiang Aili,Yao Xue Yan,YuLin Lai,Shaoqing Niu,Shasha He,Xiaokai Zhang,Guixiong Zhang,Jiaping Li

Frontiers in Oncology（2022）

引用1浏览0WOS引用

OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism (vol 12, 977348, 2022)

Jie Wen,Abudureyimujiang Aili,Yao Xue Yan,YuLin Lai,Shaoqing Niu,Shasha He,Xiaokai Zhang,Guixiong Zhang,Jiaping Li

FRONTIERS IN ONCOLOGY (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn